Fremont, CA, United States of America

Zahedeh Hatamkhani

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Alza Corporation. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zahedeh Hatamkhani. Retrieved from https://idiyas.com/inventor/zahedeh-hatamkhani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Zahedeh Hatamkhani

Introduction

Zahedeh Hatamkhani, based in Fremont, CA, is an accomplished inventor known for his significant contributions to pharmacology. With two patents to his name, Hatamkhani has focused on developing improved methods of administering antidepressant medications, reflecting his commitment to enhancing mental health treatments.

Latest Patents

Hatamkhani's recent innovations include two pivotal patents:

1. **Antidepressant Dosage Form** - This invention pertains to a dosage form and the administration of an antidepressant medicament for an extended period, utilizing a rate-known dose to improve efficacy and patient compliance.

2. **Method of Administering Antidepressant Dosage Form** - Similar to his previous patent, this invention also focuses on a novel dosage form and method, emphasizing the importance of controlled dosing over extended periods for optimal therapeutic outcomes.

Career Highlights

Zahedeh Hatamkhani currently works at Alza Corporation, a prominent company known for its advancements in drug delivery systems. His role at the corporation has allowed him to drive innovations that bridge the gap between pharmaceutical science and practical patient care.

Collaborations

In his professional journey, Hatamkhani has collaborated with esteemed coworkers such as David E. Edgren and Gurdish K. Bhatti. These partnerships have fostered a creative environment ideal for innovation and the development of new pharmaceutical solutions.

Conclusion

Zahedeh Hatamkhani's contributions to the field of antidepressant medication administration represent a significant step forward in mental health treatment. With his expertise and innovative spirit, he continues to pave the way for future advancements in pharmacology and personal well-being.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…